2010 School of Breast Oncology

Venue: Emory University Conference Center

Location: Atlanta, Georgia, United States

Event Date/Time: Nov 11, 2010 End Date/Time: Nov 14, 2010
Report as Spam


In order to advance patient care, the School of Breast Oncology was developed.This curriculum-based program focuses exclusively on breast cancer clinical management. The intensive 4-day interactive program will provide a comprehensive review of data on the most important aspects of breast cancer biology, diagnostics, prevention, and treatment. The curriculum will be evidence based, summarizing the existing data for each topic and applying these data to patient cases.

Target Audience
This educational program is directed toward medical, radiation, and surgical oncologists whose primary practice focus is breast cancer and who intend to reinforce their knowledge base and expand their expertise in breast cancer diagnosis, treatment, and management. Participants will be primarily oncologists or fellows in training whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on the pathogenesis and management of breast cancer.

Learning Objectives
At the conclusion of this conference, you should be able to:

Discuss breast carcinogenesis and the impact of germline mutations on patient management
Explain the clinical utility and limitations of sentinel lymph node biopsy
Integrate current staging guidelines into clinical decision making regarding local and systemic therapies
Discuss advances in breast cancer imaging and early detection, including mammography, ultrasound, MRI, and PET scanning
Integrate prognostic and predictive factors for breast cancer into patient management decisions and assess the optimal means of HER2 and hormone receptor expression analysis
Assess optimal radiation therapy strategies for treatment of patients with DCIS, early-stage, and locally advanced breast cancer
Critically analyze the data guiding the choice of adjuvant chemotherapies, endocrine therapies, or targeted agents for patients with low- and high-risk breast cancer and for elderly patients
Evaluate the evidence guiding treatment recommendations for the management of patients with hormone-dependent and hormone-independent metastatic breast cancer
Evaluate organ-specific therapeutic interventions for patients with metastatic disease to the CNS and skeleton
Integrate palliative care strategies into treatment algorithms for metastatic disease
List novel chemotherapies and targeted agents currently under evaluation for the treatment of advanced and early-stage breast cancer
Describe current and emerging strategies for ameliorating or eliminating therapy-associated adverse events
Assess the evidence supporting an emphasis on quality of life and rehabilitation during and after breast cancer treatment
Refer appropriate patients to promising clinical trials


1615 Clifton Rd.
United States

Additional Information

Continuing Education Information Physicians: Physicians’ Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Physicians’ Education Resource designates this educational activity for a maximum of 25.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA category 1 CME credit for the PRA from organizations accredited by the ACCME.